MOBIUS THERAPEUTICS

MITOSOL

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

MOBIUS THERAPEUTICS

Mitosol HCPCS:

J7315

HCPCS Code Descriptor:

Mitomycin, ophthalmic, 0.2 mg

Category:

J Code

Mitosol NDCs:

49771-0002-01, 49771-0002-03

Primary Type:

Ophthalmic

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Ophthalmic

Mitosol CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

49771-0002-03, 49771-0002-01

About Mitosol:

MITOSOL is a Ophthalmic drug manufactured by MOBIUS THERAPEUTICS and administered via the Ophthalmic route of administration. The J Code: J7315 is aligned to the drug MITOSOL.

ACCESS PRICING AND MORE BY REGISTERING

J7315 Added Date:

January 1, 2013

J7315 Effective Date:

January 1, 2016

J7315 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Mitosol billing and coding information.
Our team did not identify a source for Mitosol patient assistance information. Please reach out to our team if you feel that this is a mistake.
MITOSOL prescribing information can be found at the link below:
Information regarding MITOSOL’s side effects can be found at MedlinePlus